Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database Meeting Abstract
| Authors: | Ou, F. S.; Lou, Y.; Van Cutsem, E.; Saltz, L.; Schmoll, H. J.; Goldberg, R. M.; Hoff, P.; Douillard, J. Y.; Hecht, J. R.; Hurwitz, H.; Punt, C. J. A.; Bokemeyer, C.; Fuchs, C. S.; Diaz-Rubio, E.; Tebbut, N.; Falcone, A.; Kabbinavar, F. F.; De Gramont, A.; Grothey, A.; Shi, Q. |
| Abstract Title: | Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database |
| Meeting Title: | 2018 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000436174100588 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.4_suppl.612 |
| Notes: | Meeting Abstract: 612 -- Source: Wos |
